The Patent Finder
US

Antibodies Specific for Claudin 6 (CLDN6)

US 9,487,584 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Ganymed Pharmaceuticals AG, an earlier holder on the record. The recorded assignments below show how it moved.

Term ends Nov 11, 2030 · High confidence

Filed Aug 13, 2012 as application 13/503,461 · Granted Nov 8, 2016
Base term, 20 years from filing
Today
20 years from filing
2010 2030
Clock starts
Nov 11, 2010
Term ends
Nov 11, 2030
Granted
Nov 8, 2016
base term fee events Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 9,321,842, US 9,718,886, to Nov 11, 2030. The term already ends on or before that date, so the cap shortened nothing.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Nov 11, 2010, when application PCT/EP2010/006888, the earliest non-provisional in its chain, was filed (this one was filed Aug 13, 2012)Nov 11, 2030High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 9,321,842, US 9,718,886)resolves to Nov 11, 2030, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderNov 11, 2030High confidence

Partial family

Application PCT/EP2010/006888PCT application
no patent term
no patent term
US 9,487,584this patent
Nov 2030
Nov 2030
US 9,932,401In force
Nov 2030
Nov 2030
US 10,745,477In force
Nov 2030
Nov 2030
US 11,858,988In force
Nov 2030
Nov 2030
Application 18/520,242Pending
not computed
not computed
Partial: 1 of the 6 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Aug 21, 2014
Reel 33579, frame 590
Sahin, Ugur; Tureci, Ozlem; Koslowski, Michael; Walter, Korden; Woll, Stefan; Kreuzberg, Maria; Hubner, Bernd; Erdeljan, MichaelGanymed Pharmaceuticals AGAssignment of Assignor's Interest
Aug 29, 2014
Reel 33663, frame 412
Sahin, Ugur; Tureci, Ozlem; Koslowski, Michael; Walter, Korden; Woll, Stefan; Kreuzberg, Maria; Hubner, Bernd; Erdeljan, MichaelGanymed Pharmaceuticals AG; Johannes Gutenberg-Universitat MainzCorrective Assignment to Correct the Assignee Information Previously Recorded on Reel 033579 Frame 0590. Assignor(S) Hereby Confirms the Assignees Should Be Ganymed Pharmaceuticals Ag Together with Johannes Gutenberg-Universitat Mainz.
Aug 29, 2014
reel/frame not recorded
Tureci, Ozlem; Woll, Stefan; Sahin, Ugur; Kreuzberg, Maria; Walter, Korden; Hubner, Bernd; Koslowski, Michael; Erdeljan, MichaelGanymed Pharmaceuticals AGCorrective Assignment to Correct the Assignee Information Previously Recorded on Reel 033579 Frame 0590. Assignor(S) Hereby Confirms the Assignees Should Be Ganymed Pharmaceuticals Ag Together with Johannes Gutenberg-Universitat Mainz.
Aug 29, 2014
reel/frame not recorded
Tureci, Ozlem; Woll, Stefan; Sahin, Ugur; Kreuzberg, Maria; Walter, Korden; Hubner, Bernd; Koslowski, Michael; Erdeljan, MichaelJohannes Gutenberg-Universitat MainzCorrective Assignment to Correct the Assignee Information Previously Recorded on Reel 033579 Frame 0590. Assignor(S) Hereby Confirms the Assignees Should Be Ganymed Pharmaceuticals Ag Together with Johannes Gutenberg-Universitat Mainz.
Jul 7, 2020
Reel 53135, frame 922
Ganymed Pharmaceuticals AGGanymed Pharmaceuticals GmbHChange of Name
Aug 4, 2025
Reel 71926, frame 811
Ganymed Pharmaceuticals GmbHAstellas Pharma Inc.Assignment of Assignor's Interest
Nov 10, 2025
Reel 72847, frame 700
Johannes Gutenberg-Universität MainzTron - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg Universität Mainz GmbHAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited